CG Oncology · 1 day ago
Senior Enterprise Systems Administrator
CG Oncology is a biotech company focused on innovative oncology therapies and is seeking a Senior Enterprise Systems Administrator. This role involves owning and leading clinical, quality, and regulatory enterprise systems, ensuring compliance and scalability as the company grows its pipeline.
BiotechnologyHealth CareHealth DiagnosticsOncology
Responsibilities
Own and lead CG Oncology’s clinical, quality, and regulatory enterprise systems (eTMF, CTMS, EDC, IRT, QMS, Veeva QualityDocs & Training, RIM Vault)
Ensure systems are inspection-ready, compliant, and adopted across global Phase I–III trials
Act as the business owner for systems strategy, validation oversight, continuous improvement, and user enablement
Partner with CROs and vendors to ensure data quality, timelines, and budget discipline
Play a visible role in regulatory inspections, audits, and submissions
Help shape how systems scale as CG Oncology grows its pipeline
Qualification
Required
Have 7+ years of progressive experience supporting enterprise clinical and quality systems in biotech, pharma, or a CRO
Have supported full-cycle drug development (Phase I–III or I–IV), including audits or inspections
Understand GCP, ICH, FDA expectations, and clinical data stewardship deeply
Are comfortable owning systems, influencing cross-functional stakeholders, and working with external partners
Thrive in a small, fast-moving biotech environment where priorities evolve and ownership matters
Prefer roles where impact, accountability, and growth matter more than job titles alone
Preferred
Oncology experience
Small-biotech experience
Prior people leadership
Benefits
HIGHLY COMPETITIVE SALARIES
ANNUAL PERFORMANCE/MERIT REVIEWS
ANNUAL PERFORMANCE BONUSES
EQUITY
SPECIAL RECOGNITION
FULLY REMOTE WORK ENVIRONMENT
REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off
HOLIDAYS –In 2026 we will observe 14 holidays
RETIREMENT – 401K with 100% company Safe Harbor match up to 4% of base salary
HEALTH (MEDICAL, DENTAL, VISION) – PPO & HDHP – Cigna/Principal
HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
ILLNESS & DISABILITY PROTECTION – Company Paid LTD Coverage + Voluntary Plans
LIFE INSURANCE – Company Paid 1 x base salary + Voluntary Plans
ADDITIONAL EXCLUSIVE BENEFITS – Voluntary Legal, Pet, Plus More
Company
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Funding
Current Stage
Public CompanyTotal Funding
$555.57MKey Investors
Kissei PharmaceuticalORI CapitalAlly Bridge Group
2024-12-12Post Ipo Equity· $238M
2024-01-25IPO
2023-08-02Series F· $105M
Recent News
Orange County Business Journal
2026-01-22
Company data provided by crunchbase